BNGO

BNGO

USD

Bionano Genomics Inc. Common Stock

$3.700+0.030 (0.817%)

Preço em tempo real

Healthcare
Medical Instruments & Supplies
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$3.670

Máximo

$3.780

Mínimo

$3.660

Volume

0.05M

Fundamentos da empresa

Capitalização de mercado

12.4M

Setor

Medical Instruments & Supplies

País

United States

Estatísticas de negociação

Volume médio

0.14M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $2.68Atual $3.700Máximo $52.2

Notícias relacionadas

Analyst Upgrades

Maxim Group Upgrades Bionano Genomics to Buy, Announces $8 Price Target

Maxim Group analyst Jason McCarthy upgrades Bionano Genomics from Hold to Buy and announces $8 price target.

Ver mais
Maxim Group Upgrades Bionano Genomics to Buy, Announces $8 Price Target
GlobeNewswire

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today reported financial results for the first quarter ended March 31, 2025. "The first quarter of 2025 represents the first full

Ver mais
Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress
GlobeNewswire

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 14, 2025, at 4:30 p.m. Eastern Time to report

Ver mais
Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025
GlobeNewswire

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (NASDAQ:BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome

Ver mais
International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers